SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/B8F43E2E38B71D137865730D7DDF0D67B30D20937389DD3294804B83C73D6B4F9184AE072190A246A256F077E2345B3D>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/B8F43E2E38B71D137865730D7DDF0D67B30D20937389DD3294804B83C73D6B4F9184AE072190A246A256F077E2345B3D
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/B8F43E2E38B71D137865730D7DDF0D67B30D20937389DD3294804B83C73D6B4F9184AE072190A246A256F077E2345B3D
http://www.w3.org/2000/01/rdf-schema#comment
"Data report that Met protein expression and phosphorylation were associated with primary resistance to EGFR TKI therapy in NSCLC patients harboring EGFR mutations implicating Met as a de novo mechanism of resistance."
xsd:string
http://purl.uniprot.org/uniprot/#_346C412482F2FE9DA0838130A2E7433D64F6ABC678D12F3D071B5D157679E43D6BB6C5C65325B39FA6D7936368B9C45A
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/B8F43E2E38B71D137865730D7DDF0D67B30D20937389DD3294804B83C73D6B4F9184AE072190A246A256F077E2345B3D
http://purl.uniprot.org/uniprot/C9JYS6
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B8F43E2E38B71D137865730D7DDF0D67B30D20937389DD3294804B83C73D6B4F9184AE072190A246A256F077E2345B3D
http://purl.uniprot.org/uniprot/#_C9JYS6-mappedCitation-20489150
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/B8F43E2E38B71D137865730D7DDF0D67B30D20937389DD3294804B83C73D6B4F9184AE072190A246A256F077E2345B3D